ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesB38.3

B38.3

Candidiasis of vulva and vagina

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 B38.3 is a billable code used to indicate a diagnosis of candidiasis of vulva and vagina.

Key Diagnostic Point:

Candidiasis of the vulva and vagina, commonly known as a yeast infection, is a fungal infection caused primarily by the overgrowth of Candida species, particularly Candida albicans. This condition is characterized by symptoms such as itching, burning, and abnormal vaginal discharge, which may appear thick and white, resembling cottage cheese. The infection can occur in women of all ages but is more prevalent in those who are pregnant, diabetic, or immunocompromised. Factors contributing to the development of candidiasis include antibiotic use, hormonal changes, and a weakened immune system. Diagnosis is typically made based on clinical symptoms and confirmed through laboratory tests, including wet mount microscopy or culture. Treatment usually involves antifungal medications, which can be administered topically or orally, depending on the severity and recurrence of the infection. In immunocompromised patients, such as those with HIV/AIDS or undergoing chemotherapy, candidiasis can be more severe and may require more aggressive treatment and monitoring.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiating between candidiasis and other vulvovaginal infections.
  • Identifying underlying conditions that may predispose patients to recurrent infections.
  • Documenting the severity and frequency of episodes for appropriate treatment coding.
  • Understanding the implications of antifungal resistance in treatment plans.

Audit Risk Factors

  • Inadequate documentation of symptoms and treatment response.
  • Failure to document underlying conditions that may affect treatment.
  • Misclassification of candidiasis as a bacterial infection.
  • Inconsistent coding for recurrent infections.

Specialty Focus

Medical Specialties

Obstetrics and Gynecology

Documentation Requirements

Detailed patient history, including previous infections and treatments, and current symptoms.

Common Clinical Scenarios

Patients presenting with recurrent yeast infections, pregnant patients with candidiasis, and patients with comorbidities.

Billing Considerations

Consideration of pregnancy-related changes and potential complications.

Infectious Disease

Documentation Requirements

Comprehensive documentation of immunocompromised status and treatment history.

Common Clinical Scenarios

Patients with HIV/AIDS or those undergoing immunosuppressive therapy presenting with candidiasis.

Billing Considerations

Monitoring for systemic candidiasis in severely immunocompromised patients.

Coding Guidelines

Inclusion Criteria

Use B38.3 When
  • According to ICD
  • 10 coding guidelines, B38
  • 3 should be used when the condition is specifically diagnosed as candidiasis of the vulva and vagina
  • It is important to document the clinical findings and any relevant patient history

Exclusion Criteria

Do NOT use B38.3 When
  • Exclusion criteria include other specified infections of the vulva and vagina

Related CPT Codes

87210CPT Code

Culture, fungal, any source

Clinical Scenario

Used when a culture is taken to confirm candidiasis.

Documentation Requirements

Document the site of culture and the reason for testing.

Specialty Considerations

Obstetrics and Gynecology may frequently order this test for symptomatic patients.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of candidiasis, improving the accuracy of data collection and treatment tracking. This specificity aids in better understanding the epidemiology of the condition and enhances patient care.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of candidiasis, improving the accuracy of data collection and treatment tracking. This specificity aids in better understanding the epidemiology of the condition and enhances patient care.

Reimbursement & Billing Impact

reimbursement.

Resources

Clinical References

  • •
    CDC - Candidiasis

Coding & Billing References

  • •
    CDC - Candidiasis

Frequently Asked Questions

What are the common treatments for candidiasis of the vulva and vagina?

Common treatments include topical antifungal creams such as clotrimazole or miconazole, and oral antifungal medications like fluconazole. The choice of treatment may depend on the severity and frequency of infections.